Shares of GoPro, Inc. (GPRO) are trading up on the day and are moving higher despite estimate cuts below Street by analysts at Citigroup (C). The banking giant keeps $90 price target.
On valuation measures, GoPro Inc. stock it’s trading at a forward P/E multiple of 17.49x, and at a multiple of 32.72x this year’s estimated earnings. The t-12-month revenue at GoPro Inc. is $1.70 billion. GPRO ‘s ROE for the same period is 41.58%.
Shares of the $4.86 billion market cap company are down 45.22% year-over-year and 43.48% year-to-date.
GoPro Inc., currently with a median Wall Street price target of $71.00 and a high target of $105.00, rose $0.84 to $36.56 in recent trading.
—
Oracle Corporation (ORCL) was reiterated a ‘Buy’ by Stifel analysts on Thursday. The broker however, cut its price target on the stock to $45 from $47.
Shares have traded today between $36.50 and $37.67 with the price of the stock fluctuating between $35.14 to $46.71 over the last 52 weeks.
Oracle Corp. shares are currently changing hands at 16.78x this year’s forecasted earnings, compared to the industry’s 2.01x earnings multiple. Ticker has a t-12 price/sales ratio of 4.34. EPS for the same period registers at $2.21.
Shares of Oracle have lost $1.20 to $37.07 in midday trading on Thursday, giving it a market cap of roughly $161 billion. The stock traded as high as $46.71 in Dec. 24, 2014.
—
FedEx Corporation (FDX) was reiterated as ‘Buy’ with a $175 from $195 price target on Thursday by UBS.
FedEx Corp. recently traded at $150.13, a gain of $0.50 over Wednesday’s closing price. The name has a current market capitalization of $42.41 billion.
As for passive income investors, the company pays shareholders $1.00 per share annually in dividends, yielding 0.66%.
—
Shares of Yahoo! Inc. (YHOO) are down $0.45 to $30.95 in mid-day trading after FBR Capital lowered its target price on the name by 11 points to $39 a share to reflect the change in the value of Alibaba (BABA) and its impact on sum-of-the-parts valuation.
YHOO shares recently lost $0.37 to $31.03. In the past 52 weeks, shares of Sunnyvale, California-based company have traded between a low of $29.00 and a high of $52.62.
Shares are down 37.83% since the beginning of year.
—
Mirati Therapeutics, Inc. (MRTX) had its rating lowered from ‘Overweight’ to ‘Neutral’ by analysts at Piper Jaffray on Thursday. The firm sees shares as fairly valued at $45 from $50, versus $44.34 close. Currently there are 4 analysts that rate MRTX a ‘Buy’ versus zero rating it a ‘Sell’ or a ‘Hold’.
MRTX was down $2.53 at $41.81 in mid-day trade, moving within a 52-week range of $13.69 to $52.00. The name, valued at $686.30 million, opened at $42.93.
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!
Leave a Reply